TerrAscend Q1 2026: revenue $65.5M, adj EBITDA $17.4M, 15th consecutive positive cash flow

TerrAscend Corp.

2026-Q1 EPS reported -$0.03 revenue$65,539,000

Net revenue $65.5M, +1.9% YoY; gross margin 52.8% vs 53.9% a year ago.
GAAP net loss from cont ops $6.8M vs $7.7M YoY; Adj EBITDA $17.4M (26.5% margin).
Net cash from cont ops $8.7M; free cash flow $7.8M; 15th straight quarter positive ops cash flow.
U.S. medical cannabis rescheduled to Schedule III post-quarter, eliminating 280E tax on medical cannabis.
Appointed Eric Jackson as CFO effective April 2026; executed NCIB repurchases of 115k shares at ~$0.66.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.